Home> Products> gliempaflozin 10mg blood sugar control

{ "products": [ { "_id": "67a35691f802c88560805614", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "Empagliflozin (10mg)", "description": "GLIEMPAFLOZIN 10 is a prescription medication containing Empagliflozin (10mg), a highly effective oral antidiabetic drug used to manage type 2 diabetes mellitus (T2DM). It belongs to the class of SGLT2 inhibitors (Sodium-Glucose Co-Transporter 2 Inhibitors) and helps lower blood sugar levels by promoting glucose excretion through urine. This medication is designed to improve glycemic control in adults with diabetes while also offering cardiovascular and renal benefits.\n\n \nKey Benefits:\n \n\nEffective Blood Sugar Control: Helps reduce HbA1c levels, leading to better diabetes management.\n\nWeight Management: May contribute to weight loss by eliminating excess glucose through urine.\n\nHeart Health Benefits: Reduces the risk of cardiovascular complications in diabetic patients.\n\nKidney Protection: Helps in slowing the progression of diabetic nephropathy, offering renal protective benefits.\n\nLower Risk of Hypoglycemia: Since it works independently of insulin, it has a lower risk of causing low blood sugar episodes.\n\nImproves Insulin Sensitivity: Enhances glucose utilization by the body, promoting better metabolic health.\n\n \nHow Does It Work?\n \n\nGLIEMPAFLOZIN 10 functions by inhibiting the SGLT2 protein in the kidneys. Normally, this protein facilitates glucose reabsorption in the renal tubules, preventing it from being expelled through urine. By blocking SGLT2, Empagliflozin prevents glucose reabsorption, leading to increased glucose excretion and lower blood sugar levels. Additionally, it reduces blood pressure, body weight, and the risk of cardiovascular diseases, making it a comprehensive treatment option for diabetes.\n\n \nDirections for Use:\n \n\nTake one tablet of GLIEMPAFLOZIN 10 once daily, with or without food, as prescribed by your doctor.\n\nSwallow the tablet whole with a glass of water.\n\nFollow a healthy diet and regular exercise routine alongside medication for optimal results.\n\nDo not skip doses or stop taking the medication without consulting your healthcare provider.\n\n \nSide Effects:\n \n\nWhile GLIEMPAFLOZIN 10 is well-tolerated, some individuals may experience mild to moderate side effects, including:\n\nFrequent urination due to increased glucose excretion.\n\nDehydration and dizziness, especially in hot weather or when not drinking enough fluids.\n\nUrinary tract infections (UTIs) or genital yeast infections due to higher sugar levels in urine.\n\nLow blood pressure (hypotension) in some patients.\n\nIncreased cholesterol levels in certain cases.\n\nKetoacidosis (rare but serious), which requires immediate medical attention.", "price": 135.0, "discountamount": 41.0, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 1, "_keywords": [ "gliempaflozin 10", "lower risk", "prescription medication", "diabetes directions", "medical attention", "hot weather", "experience mild", "stop taking", "skip doses", "optimal results", "healthy diet", "water follow", "doctor swallow", "sglt2 protein", "metabolic health", "works independently", "weight loss", "empagliflozin 10mg", "empagliflozin 10mggliempaflozin 10", "cardiovascular complications", "offering cardiovascular", "body promoting", "cardiovascular diseases making", "promoting glucose excretion", "cases ketoacidosis rare", "higher sugar levels", "frequent urination due", "moderate side effects", "comprehensive treatment option", "increased glucose excretion", "renal tubules preventing", "eliminating excess glucose", "improve glycemic control" ], "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 2042, "imageuri": "https://productimages.withfloats.com/actual/67a356d6b85688fc926014bf.png", "tileimageuri": "https://productimages.withfloats.com/tile/67a356d6b85688fc926014bf.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2025-02-05T12:16:17.708Z", "updatedon": "2025-03-17T11:05:58.966Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM/products/empagliflozin-10mg-/2042", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "GLIEMPAFLOZIN 10 ", "category": "DIABETIC RANGE", "tags": [ "Empagliflozin 10mg price", "Empagliflozin 10 mg brand name", "Empagliflozin 10 mg brands in India", "Empagliflozin side effects", "Empagliflozin 10 mg vs 25 mg efficacy" ], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": null, "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.0, "isnotforsale": false }, { "_id": "6825c6cc966e2a18bb4b35a6", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "GLIDAPA PIO", "description": "GLIDAPA PIO is a combination oral medication specially formulated to help manage type 2 diabetes mellitus. It combines two powerful antidiabetic agents, dapagliflozin and pioglitazone, to effectively control blood sugar levels. This medication is prescribed to patients when diet and exercise alone do not provide adequate glycemic control. By addressing blood glucose regulation through different mechanisms, GLIDAPA PIO helps reduce the risk of diabetes-related complications and supports overall metabolic health.\n\nKey Ingredients\nDapagliflozin (10mg): A sodium-glucose co-transporter 2 (SGLT2) inhibitor that helps lower blood sugar by increasing the excretion of glucose through urine.\n\nPioglitazone (15mg): A thiazolidinedione that improves insulin sensitivity by acting on fat, muscle, and liver cells, facilitating better glucose uptake and utilization.\n\nKey Benefits\nHelps maintain stable blood glucose levels in adults with type 2 diabetes.\n\nCombines two complementary mechanisms to enhance blood sugar control.\n\nSupports weight management due to dapagliflozin’s glucose excretion effect.\n\nMay improve insulin sensitivity and reduce insulin resistance.\n\nReduces the risk of diabetes-related complications such as cardiovascular problems when combined with lifestyle changes.\n\nConvenient once-daily tablet formulation.\n\nHow Does It Work?\nDapagliflozin blocks SGLT2 proteins in the kidneys, preventing glucose reabsorption and promoting its elimination through urine, which lowers blood glucose. Pioglitazone acts on insulin-responsive tissues, enhancing the body’s sensitivity to insulin. This dual action helps reduce both insulin resistance and excess blood glucose, providing better overall glycemic control. By targeting different pathways, GLIDAPA PIO offers a synergistic effect to manage type 2 diabetes more effectively.\n\nDirections for Use\nTake GLIDAPA PIO exactly as prescribed by your healthcare provider.\n\nUsually taken once daily, with or without food, at the same time each day.\n\nDo not skip doses or stop the medication without consulting your doctor.\n\nMaintain a balanced diet and regular exercise as advised alongside the medication.\n\nInform your doctor about any other medications you are taking to avoid potential interactions.\n\nSide Effects\nSome patients may experience side effects while taking GLIDAPA PIO, including:\n\nUrinary tract infections or increased urination due to dapagliflozin.\n\nWeight gain or swelling caused by pioglitazone.\n\nRisk of low blood sugar (hypoglycemia) when combined with other antidiabetic drugs.\n\nPossible dizziness or fatigue.\n\nRarely, heart failure or bladder cancer risk (associated with pioglitazone).\n\nIf you notice symptoms like excessive thirst, sudden weight gain, swelling, shortness of breath, or any allergic reactions, seek medical advice immediately.", "price": 255.0, "discountamount": 77.0, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 1, "_keywords": [ "medication inform", "pioglitazone risk", "regular exercise", "balanced diet", "doctor maintain", "glucose uptake", "notice symptoms", "antidiabetic drugs", "swelling caused", "advised alongside", "skip doses", "healthcare provider", "effectively directions", "synergistic effect", "glycemic control", "cardiovascular problems", "complementary mechanisms", "fat muscle", "diabetesrelated complications", "insulin resistance", "bodys sensitivity", "glidapa pio", "urine pioglitazone 15mg", "taking glidapa pio", "bladder cancer risk", "improve insulin sensitivity", "improves insulin sensitivity", "glidapa pioglidapa pio", "dapagliflozin weight gain", "increased urination due", "urinary tract infections", "experience side effects", "insulinresponsive tissues enhancing", "liver cells facilitating" ], "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 2114, "imageuri": "https://productimages.withfloats.com/actual/6825c6ce65488af627fb2e46.png", "tileimageuri": "https://productimages.withfloats.com/tile/6825c6ce65488af627fb2e46.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2025-05-15T10:49:48.361Z", "updatedon": "2025-05-15T10:50:30.602Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM/products/glidapa-pio/2114", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "Dapagliflozin 10mg and pioglitazone 15mg tablets", "category": "DIABETIC RANGE", "tags": [ "Dapagliflozin, pioglitazone combination", "Dapagliflozin, pioglitazone combination", "Dapagliflozin Pioglitazone CDSCO" ], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": null, "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.0, "isnotforsale": false }, { "_id": "66d6c6e49c64df098caefc78", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "Atorvastatin (10 mg), Ezetimibe IP(10mg)", "description": "ATOVASTRIN EZ 10/10\nAtorvastatin (10 mg), Ezetimibe IP(10mg)\nATOVASTRIN EZ 10/10 is a potent cholesterol-lowering medication that combines two active ingredients, Atorvastatin (10 mg) and Ezetimibe IP (10 mg), to effectively manage and reduce elevated cholesterol levels. This combination therapy is designed for individuals who require more than just dietary changes and exercise to control their cholesterol levels. ATOVASTRIN EZ 10/10 is particularly beneficial for patients at high risk of cardiovascular diseases, such as heart attacks and strokes, providing a dual mechanism to lower bad cholesterol (LDL) and total cholesterol in the blood.\n\n \n\nKey Benefits:\n \n\nEffective Cholesterol Reduction: ATOVASTRIN EZ 10/10 significantly lowers LDL cholesterol, total cholesterol, and triglycerides while increasing HDL (good cholesterol) levels, promoting better cardiovascular health.\n\nDual Mechanism: The combination of Atorvastatin and Ezetimibe offers a comprehensive approach to managing cholesterol levels by both reducing the production of cholesterol in the liver and decreasing its absorption from the diet.\n\nCardiovascular Protection: By effectively lowering cholesterol levels, ATOVASTRIN EZ 10/10 helps reduce the risk of heart attacks, strokes, and other cardiovascular events, especially in individuals with a history of heart disease or high cholesterol.\n\nConvenient Dosage: The combination of two effective ingredients in a single tablet simplifies treatment regimens, improving patient compliance and outcomes.\n\nSupports Overall Health: Lowering cholesterol levels contributes to better overall health by reducing the strain on the heart and blood vessels, thereby lowering the risk of developing more severe health issues.\n\n \n\nHow Does It Work?\n \n\nATOVASTRIN EZ 10/10 works through a dual-action mechanism:\n\nAtorvastatin: By inhibiting the enzyme HMG-CoA reductase in the liver, Atorvastatin reduces the liver's production of cholesterol. This decrease in cholesterol production leads to a lower level of LDL cholesterol in the blood.\n\nEzetimibe: This ingredient targets the absorption of cholesterol in the small intestine. By blocking the absorption of dietary cholesterol, Ezetimibe reduces the amount of cholesterol that enters the bloodstream, further lowering LDL cholesterol levels.\n\nThis dual action makes ATOVASTRIN EZ 10/10 a powerful option for individuals who need to lower their cholesterol levels more effectively than with a statin alone.\n\n \n\nDirections for Use:\n \n\nDosage: Take one tablet of ATOVASTRIN EZ 10/10 daily, or as prescribed by your healthcare provider. It is typically taken once a day with or without food.\n\nConsistency: For best results, take the medication at the same time each day. This helps maintain a consistent level of the medication in your bloodstream.\n\nFollow the Prescription: Do not alter the dosage or frequency without consulting your healthcare provider. Continue taking the medication even if you feel well, as stopping suddenly can lead to a spike in cholesterol levels.\n\nLifestyle Changes: While taking ATOVASTRIN EZ 10/10, maintain a healthy diet, exercise regularly, and avoid smoking to maximize the medication’s benefits.\n\n \n\nSide Effects:\n \n\nWhile ATOVASTRIN EZ 10/10 is generally well-tolerated, some individuals may experience side effects. Common side effects include:\n\nMuscle Pain or Weakness: Some patients may experience muscle pain, tenderness, or weakness. If this occurs, consult your healthcare provider, as it could indicate a rare but serious condition called rhabdomyolysis.\n\nDigestive Issues: Nausea, diarrhea, or constipation may occur as your body adjusts to the medication.\n\nLiver Function: In rare cases, the medication may affect liver function, leading to symptoms like yellowing of the skin or eyes (jaundice). Regular monitoring of liver enzymes may be required.\n\nAllergic Reactions: Although rare, some individuals may experience allergic reactions, such as rash, itching, or swelling. Seek immediate medical attention if you experience difficulty breathing or severe swelling.\n\nHeadache: Some users might experience headaches, which usually diminish as the body adapts to the medication.\nFor further information: \nEMAIL: info@sterispharma.com / contact@sterispharma.com \n CALL/WHATSAPP: 7877551268, 7849827488 \n Order NOW\n", "price": 155.0, "discountamount": 46.5, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 7, "_keywords": [ "high risk", "same time", "rare cases", "one tablet", "Muscle Pain", "dual action", "lower level", "healthy diet", "Key Benefits", "Ezetimibe IP", "best results", "blood vessels", "liver enzymes", "heart disease", "heart attacks", "single tablet", "ATOVASTRIN EZ", "Liver Function", "dual mechanism", "Overall Health", "severe swelling", "powerful option", "small intestine", "bad cholesterol", "dietary changes", "consistent level", "high cholesterol", "Digestive Issues", "Convenient Dosage", "serious condition", "Lifestyle Changes", "HMG-CoA reductase", "total cholesterol", "Allergic Reactions", "Regular monitoring", "patient compliance", "treatment regimens", "combination therapy", "healthcare provider", "dietary cholesterol", "Common side effects", "difficulty breathing", "severe health issues", "dual-action mechanism", "cardiovascular health", "cholesterol production", "comprehensive approach", "LDL cholesterol levels", "two active ingredients", "cardiovascular diseases", "good cholesterol) levels", "Cardiovascular Protection", "two effective ingredients", "elevated cholesterol levels", "other cardiovascular events", "immediate medical attention", "Effective Cholesterol Reduction", "potent cholesterol-lowering medication" ], "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 1947, "imageuri": "https://productimages.withfloats.com/actual/66d6c6e8e3614a76bf43299b.jpg", "tileimageuri": "https://productimages.withfloats.com/tile/66d6c6e8e3614a76bf43299b.jpg", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2024-09-03T08:20:52.281Z", "updatedon": "2024-09-03T08:20:52.281Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM/products/atorvastatin-10-mg-ezetimibe-ip-10mg-/1947", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "ATOVASTRIN EZ 10/10 ", "category": "CARDIOLOGYRANGE", "tags": [ "atorvastatin 10 mg uses in hindi", "atorvastatin 10 mg uses", "atorvastatin (10 mg) ezetimibe ip(10mg) uses in hi", "ezetimibe ip(10mg) uses in hindi", "ezetimibe ip(10mg) uses" ], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": "", "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.0, "isnotforsale": false }, { "_id": "666159468da3a81d5c6a08d8", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "PAFAGOLD M 500 ", "description": "PAFAGOLD M 500 \nDapaflozin 10 mg + Metformin SR 500 mg\nIntroduction to PAFAGOLD M 500\nPAFAGOLD M 500 is a combination medication that includes Dapagliflozin 10mg and Metformin Hydrochloride Sustained Release (SR) 500mg. This medication is primarily used for the management of type 2 diabetes mellitus. By combining the complementary mechanisms of Dapagliflozin and Metformin, PAFAGOLD M 500 offers comprehensive glycemic control, helping patients manage their blood sugar levels effectively.\n\nWhat are Dapagliflozin and Metformin?\nOverview of Dapagliflozin\nDapagliflozin is an SGLT2 (sodium-glucose co-transporter-2) inhibitor that works by preventing the kidneys from reabsorbing glucose back into the blood, which allows glucose to be excreted in the urine. This helps lower blood sugar levels. Dapagliflozin also offers additional benefits such as weight loss and cardiovascular protection.\n\nOverview of Metformin\nMetformin is a biguanide that helps lower blood sugar levels by improving the body's sensitivity to insulin and reducing the amount of glucose produced by the liver. It also enhances peripheral glucose uptake and utilization. The sustained-release formulation ensures a prolonged effect throughout the day.\n\nBenefits of PAFAGOLD M 500\nEffective Blood Sugar Management\nPostprandial and Fasting Glucose Control: Dapagliflozin helps regulate fasting glucose levels by promoting glucose excretion through urine, while Metformin assists in lowering both fasting and postprandial (after-meal) glucose levels by promoting insulin sensitivity and reducing hepatic glucose production.\nComprehensive Glycemic Control: The combination of these two medications provides a dual mechanism of action that targets multiple pathways of glucose regulation, offering comprehensive blood sugar management.\nSupport for Diabetes Management\nDiet and Exercise Adjunct: PAFAGOLD M 500 is an excellent adjunct to diet and exercise, helping patients achieve better blood sugar control when lifestyle modifications alone are insufficient.\nReduced Risk of Complications: By maintaining more stable blood sugar levels, PAFAGOLD M 500 can help reduce the risk of long-term complications associated with diabetes, such as cardiovascular disease, neuropathy, and retinopathy.\nAdditional Health Benefits\nWeight Management: Dapagliflozin has been associated with weight loss due to the excretion of glucose and calories in the urine.\nCardiovascular Protection: SGLT2 inhibitors like Dapagliflozin have been shown to provide cardiovascular benefits, reducing the risk of heart failure and other cardiovascular events in diabetic patients.\nHow to Use PAFAGOLD M 500\nDosage and Administration\nRecommended Dosage: The typical dosage of PAFAGOLD M 500 is one tablet taken once daily. Your healthcare provider may adjust the dosage based on your individual response and blood sugar levels.\nAdministration: Take the tablet with meals to reduce the risk of gastrointestinal discomfort and enhance the effectiveness of Metformin. Swallow the tablet whole with a full glass of water.\nGuidelines for Optimal Use\nConsistent Use: For best results, take PAFAGOLD M 500 regularly as prescribed by your healthcare provider.\nMonitor Blood Sugar Levels: Regularly check your blood sugar levels to ensure the medication is effectively controlling your diabetes. Adjustments to your treatment plan may be necessary based on these readings.\nFor further information: \nEMAIL: info@sterispharma.com / contact@sterispharma.com \n CALL/WHATSAPP: 7877551268, 7849827488 \n Order Now\nhttps://www.sterisonline.com/product/pafagold-m-500-134322", "price": 180.0, "discountamount": 54.0, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 7, "_keywords": [ "day", "Diet", "body", "Order", "liver", "EMAIL", "urine", "meals", "water", "action", "amount", "kidneys", "Support", "Overview", "readings", "calories", "biguanide", "one tablet", "full glass", "neuropathy", "Dapaflozin", "PAFAGOLD M", "Guidelines", "weight loss", "information", "Optimal Use", "Adjustments", "utilization", "retinopathy", "Introduction", "Reduced Risk", "Metformin SR", "best results", "sterisonline", "Postprandial", "sterispharma", "heart failure", "CALL/WHATSAPP", "effectiveness", "Consistent Use", "treatment plan", "sodium-glucose", "Administration", "dual mechanism", "typical dosage", "two medications", "prolonged effect", "Exercise Adjunct", "SGLT2 inhibitors", "excellent adjunct", "glucose excretion", "Weight Management", "diabetic patients", "multiple pathways", "glucose regulation", "Recommended Dosage", "Dapagliflozin 10mg", "additional benefits", "insulin sensitivity", "blood sugar control", "healthcare provider", "Diabetes Management", "individual response", "meal) glucose levels", "cardiovascular disease", "combination medication", "long-term complications", "lifestyle modifications", "Fasting Glucose Control", "cardiovascular benefits", "type 2 diabetes mellitus", "transporter-2) inhibitor", "complementary mechanisms", "cardiovascular protection", "peripheral glucose uptake", "stable blood sugar levels", "Additional Health Benefits", "hepatic glucose production", "gastrointestinal discomfort", "other cardiovascular events", "sustained-release formulation", "comprehensive glycemic control", "Effective Blood Sugar Management", "comprehensive blood sugar management", "Metformin Hydrochloride Sustained Release" ], "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 1405, "imageuri": "https://productimages.withfloats.com/actual/666159486030c166b1a8a9f2.png", "tileimageuri": "https://productimages.withfloats.com/tile/666159486030c166b1a8a9f2.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2024-06-06T06:37:58.426Z", "updatedon": "2024-06-29T10:36:59.351Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM//pafagold-m-500-/1405", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "PAFAGOLD M 500 ", "category": "DIABETIC RANGE", "tags": [ "PAFAGOLD M 500", "Dapaflozin 10 mg", "Metformin SR 500 mg", "Dapagliflozin 10 mg dosage", "Dapagliflozin 10 mg price", "Dapagliflozin 10 mg side effects" ], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": "", "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.0, "isnotforsale": false }, { "_id": "66605238a743fd235821fe26", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "PAFAGOLD 10 ", "description": "PAFAGOLD 10 \nDapagliflozin (10mg)\nIntroduction to PAFAGOLD 10\nPAFAGOLD 10 contains Dapagliflozin 10mg, a medication primarily used for the management of type 2 diabetes mellitus. Dapagliflozin belongs to a class of drugs known as SGLT2 (sodium-glucose co-transporter-2) inhibitors. It helps improve blood sugar control by preventing the kidneys from reabsorbing glucose back into the blood, which allows glucose to be excreted in the urine. This medication is typically used in combination with diet and exercise to improve glycemic control in adults with type 2 diabetes.\n\nWhat is Dapagliflozin?\nOverview of Dapagliflozin\nDapagliflozin is an SGLT2 inhibitor that works by blocking the reabsorption of glucose in the kidneys. This leads to the excretion of excess glucose through urine, thereby lowering blood sugar levels. Dapagliflozin also offers additional benefits such as weight loss and cardiovascular protection.\n\nMechanism of Action\nSGLT2 Inhibition: Dapagliflozin inhibits the SGLT2 protein in the kidneys, which is responsible for reabsorbing glucose back into the bloodstream. By blocking this protein, Dapagliflozin ensures that excess glucose is excreted in the urine.\nBlood Sugar Reduction: This mechanism helps lower blood sugar levels, particularly fasting blood glucose levels, contributing to overall glycemic control.\nBenefits of PAFAGOLD 10\nEffective Blood Sugar Management\nFasting Glucose Control: PAFAGOLD 10 helps lower fasting blood glucose levels by promoting the excretion of glucose through urine.\nComprehensive Glycemic Control: By targeting glucose reabsorption in the kidneys, Dapagliflozin provides a unique mechanism of action that complements other diabetes medications, offering comprehensive blood sugar management.\nSupport for Diabetes Management\nDiet and Exercise Adjunct: PAFAGOLD 10 is an excellent adjunct to diet and exercise, helping patients achieve better blood sugar control when lifestyle modifications alone are insufficient.\nReduced Risk of Complications: By maintaining more stable blood sugar levels, PAFAGOLD 10 can help reduce the risk of long-term complications associated with diabetes, such as cardiovascular disease, neuropathy, and retinopathy.\nAdditional Health Benefits\nWeight Management: Dapagliflozin has been associated with weight loss due to the excretion of glucose and calories in the urine.\nCardiovascular Protection: SGLT2 inhibitors like Dapagliflozin have been shown to provide cardiovascular benefits, reducing the risk of heart failure and other cardiovascular events in diabetic patients.\nHow to Use PAFAGOLD 10\nDosage and Administration\nRecommended Dosage: The typical dosage of PAFAGOLD 10 is one tablet taken once daily. Your healthcare provider may adjust the dosage based on your individual response and blood sugar levels.\nAdministration: Take the tablet with or without food. Swallow the tablet whole with a full glass of water. Consistency is key, so take the medication at the same time each day.\nGuidelines for Optimal Use\nConsistent Use: For best results, take PAFAGOLD 10 regularly as prescribed by your healthcare provider.\nMonitor Blood Sugar Levels: Regularly check your blood sugar levels to ensure the medication is effectively controlling your diabetes. Adjustments to your treatment plan may be necessary based on these readings.\nFor further information: \nEMAIL: info@sterispharma.com / contact@sterispharma.com \n CALL/WHATSAPP: 7877551268, 7849827488 \n Order Now\nhttps://www.sterisonline.com/product/pafagold-10-134126", "price": 135.0, "discountamount": 40.5, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 7, "_keywords": [ "diet", "food", "drugs", "urine", "class", "EMAIL", "Order", "water", "adults", "Action", "kidneys", "Support", "calories", "PAFAGOLD", "readings", "Overview", "excretion", "same time", "Guidelines", "one tablet", "full glass", "neuropathy", "Consistency", "bloodstream", "Adjustments", "weight loss", "information", "retinopathy", "combination", "Optimal Use", "Introduction", "sterisonline", "best results", "sterispharma", "Reduced Risk", "heart failure", "SGLT2 protein", "CALL/WHATSAPP", "Administration", "sodium-glucose", "typical dosage", "treatment plan", "Consistent Use", "excess glucose", "SGLT2 inhibitor", "Exercise Adjunct", "SGLT2 Inhibition", "unique mechanism", "Weight Management", "diabetic patients", "excellent adjunct", "Dapagliflozin 10mg", "Recommended Dosage", "individual response", "healthcare provider", "blood sugar control", "Diabetes Management", "additional benefits", "glucose reabsorption", "blood glucose levels", "Blood Sugar Reduction", "cardiovascular disease", "cardiovascular benefits", "Fasting Glucose Control", "lifestyle modifications", "long-term complications", "type 2 diabetes mellitus", "overall glycemic control", "transporter-2) inhibitors", "cardiovascular protection", "stable blood sugar levels", "Additional Health Benefits", "other diabetes medications", "other cardiovascular events", "Comprehensive Glycemic Control", "Effective Blood Sugar Management", "comprehensive blood sugar management" ], "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 1386, "imageuri": "https://productimages.withfloats.com/actual/6660523bc06ee12d88ce1635.png", "tileimageuri": "https://productimages.withfloats.com/tile/6660523bc06ee12d88ce1635.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2024-06-05T11:55:36.543Z", "updatedon": "2024-06-29T11:14:01.571Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM//pafagold-10-/1386", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "PAFAGOLD 10 ", "category": "DIABETIC RANGE", "tags": [ "PAFAGOLD 10", "Dapagliflozin (10mg)", "Dapagliflozin 10mg uses", "Dapagliflozin 10mg side effects", "Dapagliflozin 10 mg price", "Dapagliflozin 10 mg dosage" ], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": "", "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.0, "isnotforsale": false }, { "_id": "66604eb566170d1ff8cb2c6a", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "LINALIGLIP DAPA 5-10 ", "description": "LINALIGLIP DAPA 5-10 \nLinagliptin 5 mg & Dapagliflozin 10 mg\nIntroduction to LINALIGLIP DAPA 5-10\nLINALIGLIP DAPA 5-10 is a combination medication that includes Linagliptin 5mg and Dapagliflozin 10mg. This medication is primarily used for the management of type 2 diabetes mellitus. By combining the complementary mechanisms of Linagliptin and Dapagliflozin, LINALIGLIP DAPA 5-10 provides comprehensive glycemic control, helping patients manage their blood sugar levels effectively.\n\nWhat are Linagliptin and Dapagliflozin?\nOverview of Linagliptin\nLinagliptin is a DPP-4 (dipeptidyl peptidase-4) inhibitor that helps regulate blood glucose levels by increasing insulin release and decreasing glucagon levels in response to meals. By enhancing incretin hormones, Linagliptin aids in maintaining better overall blood sugar control throughout the day.\n\nOverview of Dapagliflozin\nDapagliflozin is an SGLT2 (sodium-glucose co-transporter-2) inhibitor that works by preventing the kidneys from reabsorbing glucose back into the blood. Instead, it allows glucose to be excreted in the urine, thereby lowering blood glucose levels. Dapagliflozin also offers additional benefits such as weight loss and cardiovascular protection.\n\nBenefits of LINALIGLIP DAPA 5-10\nEffective Blood Sugar Management\nPostprandial and Fasting Glucose Control: Linagliptin helps regulate postprandial (after-meal) glucose levels, while Dapagliflozin assists in lowering fasting glucose levels by promoting glucose excretion through urine.\nComprehensive Glycemic Control: The combination of these two medications provides a dual mechanism of action that targets multiple pathways of glucose regulation, offering comprehensive blood sugar management.\nSupport for Diabetes Management\nDiet and Exercise Adjunct: LINALIGLIP DAPA 5-10 is an excellent adjunct to diet and exercise, helping patients achieve better blood sugar control when lifestyle modifications alone are insufficient.\nReduced Risk of Complications: By maintaining more stable blood sugar levels, LINALIGLIP DAPA 5-10 can help reduce the risk of long-term complications associated with diabetes, such as cardiovascular disease, neuropathy, and retinopathy.\nAdditional Health Benefits\nWeight Management: Dapagliflozin has been associated with weight loss due to the excretion of glucose and calories in the urine.\nCardiovascular Protection: SGLT2 inhibitors like Dapagliflozin have been shown to provide cardiovascular benefits, reducing the risk of heart failure and other cardiovascular events in diabetic patients.\nHow to Use LINALIGLIP DAPA 5-10\nDosage and Administration\nRecommended Dosage: The typical dosage of LINALIGLIP DAPA 5-10 is one tablet taken once daily. Your healthcare provider may adjust the dosage based on your individual response and blood sugar levels.\nAdministration: Take the tablet with or without food. Swallow it whole with a full glass of water. Consistency is key, so take the medication at the same time each day.\nGuidelines for Optimal Use\nConsistent Use: For best results, take LINALIGLIP DAPA 5-10 regularly as prescribed by your healthcare provider.\nMonitor Blood Sugar Levels: Regularly check your blood sugar levels to ensure the medication is effectively controlling your diabetes. Adjustments to your treatment plan may be necessary based on these readings.\nFor further information: \nEMAIL: info@sterispharma.com / contact@sterispharma.com \n CALL/WHATSAPP: 7877551268, 7849827488 \n Order Now\nhttps://www.sterisonline.com/product/linaliglip-dapa-5-10-134320", "price": 245.0, "discountamount": 73.5, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 7, "_keywords": [ "day", "food", "Diet", "Order", "urine", "EMAIL", "meals", "water", "action", "Support", "kidneys", "readings", "Overview", "calories", "same time", "full glass", "one tablet", "Guidelines", "neuropathy", "retinopathy", "Consistency", "Adjustments", "information", "Optimal Use", "weight loss", "best results", "Reduced Risk", "Postprandial", "sterispharma", "Introduction", "sterisonline", "Dapagliflozin", "heart failure", "CALL/WHATSAPP", "dual mechanism", "sodium-glucose", "typical dosage", "treatment plan", "Administration", "Consistent Use", "insulin release", "two medications", "Linagliptin 5mg", "LINALIGLIP DAPA", "glucagon levels", "linaliglip-dapa", "SGLT2 inhibitors", "Exercise Adjunct", "glucose excretion", "Weight Management", "diabetic patients", "excellent adjunct", "multiple pathways", "incretin hormones", "Recommended Dosage", "glucose regulation", "individual response", "Diabetes Management", "additional benefits", "healthcare provider", "meal) glucose levels", "blood glucose levels", "cardiovascular disease", "combination medication", "Fasting Glucose Control", "lifestyle modifications", "long-term complications", "cardiovascular benefits", "type 2 diabetes mellitus", "complementary mechanisms", "transporter-2) inhibitor", "cardiovascular protection", "stable blood sugar levels", "Additional Health Benefits", "other cardiovascular events", "overall blood sugar control", "comprehensive glycemic control", "Effective Blood Sugar Management", "dipeptidyl peptidase-4) inhibitor", "comprehensive blood sugar management" ], "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 1380, "imageuri": "https://productimages.withfloats.com/actual/66604eb74f159c14e162af6b.png", "tileimageuri": "https://productimages.withfloats.com/tile/66604eb74f159c14e162af6b.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2024-06-05T11:40:37.381Z", "updatedon": "2024-06-29T11:37:59.144Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM//linaliglip-dapa-5-10-/1380", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "LINALIGLIP DAPA 5-10 ", "category": "DIABETIC RANGE", "tags": [ "LINALIGLIP DAPA 5-10", "Linagliptin 5 mg", "Dapagliflozin 10 mg", "Dapagliflozin 10 mg dosage", "Dapagliflozin 10 mg price", "Dapagliflozin 10 mg Uses in Hindi", "Dapagliflozin 10 mg side effects" ], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": "", "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.0, "isnotforsale": false }, { "_id": "665f0a9787f0960e14a296d5", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "GLIDAPAFLOZIN M 10/1000 ", "description": "GLIDAPAFLOZIN M 10/1000 \nDapagliflozin (10mg), Metformin (1000mg)\nIntroduction\nGLIDAPAFLOZIN M 10/1000 is a potent combination medication designed to effectively manage Type 2 diabetes. It combines Dapagliflozin (10 mg) and Metformin (1000 mg), providing a dual-action approach to blood glucose control and overall metabolic health.\n\nMechanism of Action\n\nDapagliflozin (10 mg): Dapagliflozin is an SGLT2 inhibitor that works in the kidneys to reduce glucose reabsorption, leading to increased urinary glucose excretion. This action helps lower blood glucose levels and can also promote weight loss and cardiovascular benefits.\nMetformin (1000 mg): Metformin is a cornerstone medication for Type 2 diabetes, improving insulin sensitivity, reducing liver glucose production, and decreasing intestinal glucose absorption. It helps lower blood sugar levels and may also support weight management.\nBenefits\nGLIDAPAFLOZIN M 10/1000 offers several advantages for individuals with Type 2 diabetes. By combining Dapagliflozin and Metformin at higher doses, it provides comprehensive control over blood glucose levels and metabolic parameters. This combination can lead to improved glycemic control, weight management, and cardiovascular health.\n\nDosage and Administration\n\nDosage: The recommended dose is one tablet per day, taken with a meal to minimize gastrointestinal side effects. Dosage adjustments may be necessary based on individual response and tolerability.\nAdministration: GLIDAPAFLOZIN M 10/1000 should be taken in the morning to maximize its effectiveness throughout the day. It is important to adhere to the prescribed dosing schedule consistently.\nSide Effects\nCommon side effects of GLIDAPAFLOZIN M 10/1000 may include urinary tract infections, genital infections, gastrointestinal disturbances (such as nausea or diarrhea), and potential vitamin B12 deficiency with long-term use. Patients should be aware of these potential side effects and report any concerns to their healthcare provider.\n\nConclusion\nGLIDAPAFLOZIN M 10/1000 provides a comprehensive and effective treatment option for individuals with Type 2 diabetes, combining the benefits of Dapagliflozin and Metformin in a single tablet. Its dual-action mechanism targets multiple aspects of diabetes management, supporting improved glycemic control and metabolic health. Patients should consult their healthcare provider for personalized advice on dosage, monitoring, and management of potential side effects.\nFor further information: \nEMAIL: info@sterispharma.com / contact@sterispharma.com \n CALL/WHATSAPP: 7877551268, 7849827488 \n Order Now\nhttps://www.sterisonline.com/product/glidapaflozin-m-10-1000-133425", "price": 205.0, "discountamount": 61.5, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 7, "_keywords": [ "day", "meal", "lower", "EMAIL", "Order", "nausea", "kidneys", "morning", "1000 mg", "diarrhea", "concerns", "improved", "Patients", "Metformin", "Conclusion", "monitoring", "one tablet", "weight loss", "information", "individuals", "higher doses", "Introduction", "sterisonline", "tolerability", "sterispharma", "effectiveness", "Dapagliflozin", "CALL/WHATSAPP", "long-term use", "single tablet", "SGLT2 inhibitor", "GLIDAPAFLOZIN M", "dosing schedule", "Type 2 diabetes", "multiple aspects", "glycemic control", "weight management", "genital infections", "blood sugar levels", "Dosage adjustments", "several advantages", "Common side effects", "healthcare provider", "insulin sensitivity", "personalized advice", "individual response", "diabetes management", "glucose reabsorption", "dual-action approach", "metabolic parameters", "blood glucose levels", "dual-action mechanism", "cardiovascular health", "comprehensive control", "Administration Dosage", "blood glucose control", "cornerstone medication", "potential side effects", "cardiovascular benefits", "overall metabolic health", "urinary tract infections", "liver glucose production", "urinary glucose excretion", "effective treatment option", "gastrointestinal side effects", "potent combination medication", "gastrointestinal disturbances", "intestinal glucose absorption", "potential vitamin B12 deficiency" ], "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 1317, "imageuri": "https://productimages.withfloats.com/actual/665f0a99c06ee12d88cb43d9.png", "tileimageuri": "https://productimages.withfloats.com/tile/665f0a99c06ee12d88cb43d9.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2024-06-04T12:37:43.401Z", "updatedon": "2024-06-04T12:37:43.401Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM/products/glidapaflozin-m-10-1000-/1317", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "GLIDAPAFLOZIN M 10/1000 ", "category": "DIABETIC RANGE", "tags": null, "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": "", "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.0, "isnotforsale": false }, { "_id": "665f081d8da3a81d5c69e8ec", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "GLIDAPAFLOZIN 10 ", "description": "GLIDAPAFLOZIN 10 \nDapagliflozin (10mg)\nIntroduction\nGLIDAPAFLOZIN 10 is a highly effective medication formulated specifically for the treatment of Type 2 diabetes. This oral tablet contains 10 mg of Dapagliflozin, an SGLT2 inhibitor that plays a crucial role in managing blood glucose levels and supporting overall cardiovascular health.\n\nMechanism of Action\n\nDapagliflozin (10 mg): Dapagliflozin operates by inhibiting the sodium-glucose cotransporter 2 (SGLT2) in the kidneys. This inhibition prevents the reabsorption of glucose back into the bloodstream, promoting the excretion of glucose through urine. This process not only helps lower blood sugar levels but also aids in calorie reduction and weight management.\nBenefits\nGLIDAPAFLOZIN 10 is particularly beneficial for patients looking to control their blood sugar levels effectively while also addressing other metabolic aspects like weight and blood pressure. It has been associated with cardiovascular benefits, making it a preferred choice for diabetic patients with heart-related concerns.\n\nDosage and Administration\n\nDosage: The recommended starting dose is one 10 mg tablet per day. Dosage adjustments should be based on individual efficacy and tolerability, under the guidance of a healthcare professional.\nAdministration: GLIDAPAFLOZIN 10 should be taken in the morning, with or without food. Consistency in taking the medication at the same time each day is important for maintaining stable glucose levels.\nSide Effects\nThe most common side effects of GLIDAPAFLOZIN 10 include genital and urinary tract infections due to the increased glucose in the urine. Patients may also experience signs of dehydration and low blood pressure. It is important for users to stay well-hydrated and monitor for signs of excessive urination and thirst.\n\nConclusion\nGLIDAPAFLOZIN 10 offers an effective, focused approach to managing Type 2 diabetes through its unique action on renal glucose processing. It simplifies diabetes management by providing a once-daily oral treatment that supports blood sugar control while potentially improving cardiovascular and metabolic health. As with any medication, it is crucial to consult a healthcare provider to tailor the treatment to individual needs and circumstances.\nFor further information: \nEMAIL: info@sterispharma.com / contact@sterispharma.com \n CALL/WHATSAPP: 7877551268, 7849827488 \n Order Now\nhttps://www.sterisonline.com/product/glidapaflozin-10-133427\n\n\n\n\n\n", "price": 240.0, "discountamount": 72.0, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 7, "_keywords": [ "day", "food", "Order", "signs", "users", "EMAIL", "urine", "thirst", "choice", "kidneys", "genital", "morning", "guidance", "same time", "Mechanism", "excretion", "Conclusion", "inhibition", "Consistency", "oral tablet", "dehydration", "information", "bloodstream", "Introduction", "reabsorption", "crucial role", "sterispharma", "tolerability", "sterisonline", "GLIDAPAFLOZIN", "circumstances", "CALL/WHATSAPP", "Dapagliflozin", "unique action", "starting dose", "oral treatment", "Type 2 diabetes", "SGLT2 inhibitor", "one 10 mg tablet", "metabolic health", "individual needs", "weight management", "diabetic patients", "calorie reduction", "blood sugar levels", "Dosage adjustments", "low blood pressure", "individual efficacy", "common side effects", "excessive urination", "diabetes management", "healthcare provider", "blood sugar control", "effective medication", "blood glucose levels", "stable glucose levels", "Administration Dosage", "heart-related concerns", "cardiovascular benefits", "healthcare professional", "other metabolic aspects", "urinary tract infections", "renal glucose processing", "effective, focused approach", "sodium-glucose cotransporter", "overall cardiovascular health" ], "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 1310, "imageuri": "https://productimages.withfloats.com/actual/665f0820c40ee9be019637c3.jpg", "tileimageuri": "https://productimages.withfloats.com/tile/665f0820c40ee9be019637c3.jpg", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2024-06-04T12:27:09.955Z", "updatedon": "2024-06-04T12:27:09.955Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM/products/glidapaflozin-10-/1310", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "GLIDAPAFLOZIN 10 ", "category": "DIABETIC RANGE", "tags": null, "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": "", "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.0, "isnotforsale": false }, { "_id": "665dbb06dce9381dfcc553b6", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "DAPA VILDA 10/100 SR ", "description": "DAPA VILDA 10/100 SR \nDapagliflozin (10mg), Vildagliptin SR (100mg)\nIntroduction to DAPA VILDA 10/100 SR\nDAPA VILDA 10/100 SR is a combination medication that includes Dapagliflozin 10mg and Vildagliptin 100mg in a sustained-release (SR) formulation. This medication is primarily used for the management of type 2 diabetes mellitus. Dapagliflozin and Vildagliptin work together to improve blood sugar control through complementary mechanisms, making this combination an effective treatment option for patients needing comprehensive glycemic management.\n\nWhat are Dapagliflozin and Vildagliptin?\nOverview of Dapagliflozin\nDapagliflozin is an SGLT2 (sodium-glucose co-transporter-2) inhibitor that works by preventing the kidneys from reabsorbing glucose back into the blood. Instead, it allows glucose to be excreted in the urine, thereby lowering blood glucose levels.\n\nOverview of Vildagliptin\nVildagliptin is a DPP-4 (dipeptidyl peptidase-4) inhibitor that enhances the body's natural incretin hormones, which help regulate blood glucose by increasing insulin release and decreasing glucagon levels in response to meals. The sustained-release formulation ensures a prolonged effect throughout the day.\n\nBenefits of DAPA VILDA 10/100 SR\nEffective Blood Sugar Management\nPostprandial and Fasting Glucose Control: Vildagliptin helps regulate postprandial (after-meal) glucose levels, while Dapagliflozin assists in lowering fasting glucose levels by promoting glucose excretion through urine.\nComprehensive Glycemic Control: The combination of these two medications provides a dual mechanism of action that targets multiple pathways of glucose regulation, offering comprehensive blood sugar management.\nWeight Management and Cardiovascular Benefits\nWeight Reduction: Dapagliflozin has been associated with weight loss due to the excretion of glucose and calories in the urine.\nCardiovascular Protection: SGLT2 inhibitors like Dapagliflozin have been shown to provide cardiovascular benefits, reducing the risk of heart failure and other cardiovascular events in diabetic patients.\nConvenience and Compliance\nOnce-Daily Dosing: The sustained-release formulation of Vildagliptin allows for once-daily dosing, improving patient compliance and convenience.\nReduced Pill Burden: Combining two effective diabetes medications into one pill simplifies the treatment regimen, making it easier for patients to adhere to their prescribed therapy.\nHow to Use DAPA VILDA 10/100 SR\nDosage and Administration\nRecommended Dosage: The typical dosage of DAPA VILDA 10/100 SR is one tablet taken once daily. Your healthcare provider may adjust the dosage based on your individual response and blood sugar levels.\nAdministration: Take the tablet with or without food, preferably at the same time each day to maintain consistent blood levels of the medication. Swallow the tablet whole with a full glass of water.\nGuidelines for Optimal Use\nConsistent Use: For best results, take DAPA VILDA 10/100 SR regularly as prescribed by your healthcare provider.\nMonitor Blood Sugar Levels: Regularly check your blood sugar levels to ensure the medication is effectively controlling your diabetes. Adjustments to your treatment plan may be necessary based on these readings.\nFor further information: \nEMAIL: info@sterispharma.com / contact@sterispharma.com \n CALL/WHATSAPP: 7877551268, 7849827488 \n Order Now\nhttps://www.sterisonline.com/product/dapa-vilda-10-100-sr-134064", "price": 210.0, "discountamount": 63.0, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 7, "_keywords": [ "day", "body", "food", "risk", "urine", "EMAIL", "Order", "meals", "water", "action", "kidneys", "one pill", "calories", "readings", "Overview", "same time", "full glass", "Guidelines", "one tablet", "Optimal Use", "Adjustments", "information", "weight loss", "Convenience", "Introduction", "Daily Dosing", "best results", "sterisonline", "sterispharma", "Postprandial", "CALL/WHATSAPP", "heart failure", "treatment plan", "Administration", "typical dosage", "dual mechanism", "Consistent Use", "sodium-glucose", "glucagon levels", "two medications", "insulin release", "Vildagliptin SR", "Weight Reduction", "prolonged effect", "SGLT2 inhibitors", "diabetic patients", "treatment regimen", "Weight Management", "glucose excretion", "multiple pathways", "Dapagliflozin 10mg", "prescribed therapy", "patient compliance", "blood sugar levels", "glucose regulation", "Recommended Dosage", "individual response", "blood sugar control", "healthcare provider", "Reduced Pill Burden", "meal) glucose levels", "blood glucose levels", "DAPA VILDA 10/100 SR", "combination medication", "Fasting Glucose Control", "consistent blood levels", "Cardiovascular Benefits", "transporter-2) inhibitor", "complementary mechanisms", "type 2 diabetes mellitus", "natural incretin hormones", "Cardiovascular Protection", "effective treatment option", "other cardiovascular events", "sustained-release formulation", "Comprehensive Glycemic Control", "Effective Blood Sugar Management", "comprehensive glycemic management", "dipeptidyl peptidase-4) inhibitor", "sustained-release (SR) formulation", "two effective diabetes medications", "comprehensive blood sugar management" ], "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 1253, "imageuri": "https://productimages.withfloats.com/actual/665dbb093b5550f17788eb4e.png", "tileimageuri": "https://productimages.withfloats.com/tile/665dbb093b5550f17788eb4e.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2024-06-03T12:45:58.06Z", "updatedon": "2024-06-03T12:45:58.06Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM/products/dapa-vilda-10-100-sr-/1253", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "DAPA VILDA 10/100 SR ", "category": "DIABETIC RANGE", "tags": null, "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": "", "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.0, "isnotforsale": false } ], "hasmoreitems": false, "isapirequest": false, "totalresults": 27, "query": null, "floatingpoint": null }